Results 171 to 180 of about 114,798 (264)

Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism

Hepatology, 2018
Preeti Pathak, Cen Xie, Robert G. Nichols, Jessica M. Ferrell, Shannon Boehme, K. Krausz, A. Patterson, F. Gonzalez, J. Chiang   +8 more
semanticscholar   +1 more source

Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review). [PDF]

Int J Mol Med
Sun Y, Sun K, Ling H, Xia Q.
europepmc   +1 more source

Impact of the gut microbiota on inflammation, obesity, and metabolic disease [PDF]

, 2016
Boulangé, CL, Chilloux, J, Dumas, ME, Neves, AL, Nicholson, JK   +4 more
core   +1 more source

Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor. [PDF]

Int J Mol Sci
Qi Y, Ma Y, Duan G.
europepmc   +1 more source

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway. [PDF]

Acta Biochim Biophys Sin (Shanghai), 2023
Yang F, Lv XT, Lin XL, Wang RH, Wang SM, Wang GE.   +5 more
europepmc   +1 more source

A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis. [PDF]

J Biol Chem
Behrendt A, Bastianelli A, Stindt J, Pfister ED, Sgodda M, Cantz T, Hook S, Gopalswamy M, Grau K, Brands S, Dröge C, Stalke A, Bonus M, Franke S, Baumann U, Keitel V, Gohlke H.   +16 more
europepmc   +1 more source

Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis. [PDF]

Front Immunol, 2023
Khan MAH, Nolan B, Stavniichuk A, Merk D, Imig JD.   +4 more
europepmc   +1 more source

Ursodeoxycholic acid alleviates aortic aneurysm and dissection through the intestinal farnesoid X receptor/ceramide synthase 2 axis. [PDF]

Commun Biol
Zhang Z, Xie L, Lin X, He J, Xie Y, Li J, Zhuang X, Tang L, Xie R, Wu Q, Qiu Z, Chen L.   +11 more
europepmc   +1 more source

[Retracted] Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway. [PDF]

Oncol Rep
Qiao P, Li S, Zhang H, Yao L, Wang F.
europepmc   +1 more source

A Twist in the Tale of a Pig Model of Short-Bowel Syndrome

, 2017
Walters, JRF
core   +1 more source